Medical Condition

crohn s disease

Total Trials

14

Recruiting Now

14

Trial Phases

Phase 4, Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for crohn s disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — crohn s disease Clinical Trials

How many clinical trials are currently recruiting for crohn s disease?

ClinicalMetric currently tracks 14 actively recruiting clinical trials for crohn s disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for crohn s disease?

crohn s disease research spans Phase 1 (2 trials), Phase 2 (5 trials), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a crohn s disease clinical trial?

Eligibility criteria for crohn s disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Phase 4

Top Sponsors

Asan Medical Center 1 trial

Sixth Affiliated Hospital, Sun Yat-sen University 1 trial

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1 trial

Weill Medical College of Cornell University 1 trial

Janssen-Cilag Ltd. 1 trial

Recruiting Clinical Trials

NCT06064864

Recruiting

Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD

Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

Sixth Affiliated Hospital, Sun...

View Trial →

NCT07619547

Recruiting

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

National Institute of Diabetes...

View Trial →

NCT07925450 Phase 4

Recruiting

Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease

Weill Medical College of Corne...

View Trial →

NCT07242248

Recruiting

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Enrollment

120 pts

Location

United States, Austr...

Sponsor

Janssen Research & Development...

View Trial →

NCT06211400

Recruiting

Vibration Exercise for Crohn's to Observe Response

University of Hertfordshire

View Trial →

NCT06533228

Recruiting

Helmsley 3.0: Abbreviated MRE

Children's Hospital Medical Ce...

View Trial →

NCT07753850 Phase 2

Recruiting

A Study of SL-325 in Crohn's Disease Patients

Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease

NCT00692939 Phase 1, Phase 2

Recruiting

Autologous Stem Cell Transplantation for Crohn's Disease

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Enrollment

385 pts

Location

United States, Austr...

Sponsor

Morphic Therapeutic, Inc. (A W...

View Trial →

NCT07113522 Phase 2

Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Enrollment

140 pts

Location

United States, Canad...

Sponsor

Mirador Therapeutics, Inc.

View Trial →

NCT03167437 Phase 1, Phase 2

Recruiting

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

National Institute of Allergy ...

View Trial →

Related Conditions

inflammatory bowel disease (3) ulcerative colitis (2) iron deficiency anemia (1) colitis ulcerative (1) inflammatory bowel diseases (1) inflammatory bowel disease ibd (1) ulcerative colitis uc (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology